{"title":"Neuroprotective role of Celastrus paniculatus Willd and Sida cordifolia Linn on kainic acid-induced neuronal damage in neurodegenerative diseases","authors":"Gajanand R Pujari, V. Subramanian, S. Rao","doi":"10.29090/psa.2022.03.21.254","DOIUrl":null,"url":null,"abstract":"Neurodegenerative diseases (NDs) are caused by the dysfunction of neurons. Neuronal death is associated with the aggregation of proteins in neurons and glial cells. The aggregated proteins impede mitochondrial function and induce oxidative stress. Increased oxidative stress produces more reactive oxygen species (ROS) which is detrimental to cells in the brain causes neuronal degeneration. There are no treatments for NDs other than reducing disease progression. Hence, the treatment strategies, which reduce oxidative stress and neuronal damage are in demand. Celastrus paniculatus Willd (CP) and Sida cordifolia Linn (SC) have been extensively used in the indigenous therapeutic systems for treating various brain-related ailments. The present investigation was carried out to examine the biochemical and histological alterations of seed oil of CP (SOCP) and aqueous root extract of SC (ARESC) on the hippocampus of the brain in Kainic acid (KA)-induced NDs. The extracts of SOCP and ARESC were administered for 14 days and KA was administered by i.p. on the 14 th day to all the groups except the vehicle control group. At the end of the study, the rat brain was removed, the hippocampus was separated, and the homogenate was prepared to estimate the antioxidant parameters (SOD, catalase, and LPO). LDH assay, dopamine (DA) level, α-synuclein immunohistochemistry, and ROS assays were conducted. The results revealed that the treatment with SOCP and ARESC increased the levels of antioxidant enzymes, reduced oxidative stress, decreased α-synuclein protein aggregation, and elevated the levels of DA neurotransmitters.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Sciences Asia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29090/psa.2022.03.21.254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Neurodegenerative diseases (NDs) are caused by the dysfunction of neurons. Neuronal death is associated with the aggregation of proteins in neurons and glial cells. The aggregated proteins impede mitochondrial function and induce oxidative stress. Increased oxidative stress produces more reactive oxygen species (ROS) which is detrimental to cells in the brain causes neuronal degeneration. There are no treatments for NDs other than reducing disease progression. Hence, the treatment strategies, which reduce oxidative stress and neuronal damage are in demand. Celastrus paniculatus Willd (CP) and Sida cordifolia Linn (SC) have been extensively used in the indigenous therapeutic systems for treating various brain-related ailments. The present investigation was carried out to examine the biochemical and histological alterations of seed oil of CP (SOCP) and aqueous root extract of SC (ARESC) on the hippocampus of the brain in Kainic acid (KA)-induced NDs. The extracts of SOCP and ARESC were administered for 14 days and KA was administered by i.p. on the 14 th day to all the groups except the vehicle control group. At the end of the study, the rat brain was removed, the hippocampus was separated, and the homogenate was prepared to estimate the antioxidant parameters (SOD, catalase, and LPO). LDH assay, dopamine (DA) level, α-synuclein immunohistochemistry, and ROS assays were conducted. The results revealed that the treatment with SOCP and ARESC increased the levels of antioxidant enzymes, reduced oxidative stress, decreased α-synuclein protein aggregation, and elevated the levels of DA neurotransmitters.
Pharmaceutical Sciences AsiaPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
0.90
自引率
0.00%
发文量
59
期刊介绍:
The Pharmaceutical Sciences Asia (PSA) journal is a double-blinded peer-reviewed journal in English published quarterly, by the Faculty of Pharmacy, Mahidol University, Thailand. The PSA journal is formerly known as Mahidol University Journal of Pharmaceutical Sciences and committed to the timely publication of innovative articles and reviews. This journal is available in both printed and electronic formats. The PSA journal aims at establishing a publishing house that is open to all. It aims to disseminate knowledge; provide a learned reference in the field; and establish channels of communication between academic and research expert, policy makers and executives in industry and investment institutions. The journal publishes research articles, review articles, and scientific commentaries on all aspects of the pharmaceutical sciences and multidisciplinary field in health professions and medicine. More specifically, the journal publishes research on all areas of pharmaceutical sciences and related disciplines: Clinical Pharmacy Drug Synthesis and Discovery Targeted-Drug Delivery Pharmaceutics Biopharmaceutical Sciences Phytopharmaceutical Sciences Pharmacology and Toxicology Pharmaceutical Chemistry Nutraceuticals and Functional Foods Natural Products Social, Economic, and Administrative Pharmacy Clinical Drug Evaluation and Drug Policy Making Antimicrobials, Resistance and Infection Control Pharmacokinetics and Pharmacodynamics.